Evidence map›Paper›PMID 26106548›Full record

ArticleNeuroImage. Clinical2015

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia.

Brian A Gordon, Safa Najmi, Phillip Hsu, Catherine M Roe, John C Morris, Tammie L S Benzinger

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Deep Learning-Based Prediction of PET Amyloid Status Using MRI.AJNR. American journal of neuroradiology · 2025
    Article
  3. Primary age-related tauopathy.Acta neuropathologica · 2025
    Review
  4. Impact of regional white matter hyperintensity patterns on cognitive trajectories in NACC.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Brian A GordonDepartment of Radiology, Washington University in St. Louis, USA ; Department of Psychology, Washington University in St. Louis, USA ; Knight Alzheimer's Disease Research Center, Washington University in St. Louis, USA.
Safa NajmiDepartment of Neurology, Tabriz University of Medical Science, Iran.
Phillip HsuPritzker School of Medicine, University of Chicago, USA.
Catherine M RoeKnight Alzheimer's Disease Research Center, Washington University in St. Louis, USA ; Department of Neurology, Washington University in St. Louis, USA.
John C MorrisKnight Alzheimer's Disease Research Center, Washington University in St. Louis, USA ; Department of Neurology, Washington University in St. Louis, USA.
Tammie L S BenzingerDepartment of Radiology, Washington University in St. Louis, USA ; Knight Alzheimer's Disease Research Center, Washington University in St. Louis, USA ; Department of Neurosurgery, Washington University in St. Louis, USA.
Washington University in St. Louis · USUniversity of Chicago · USUniversity of Tabriz · IR

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P01 AG03991NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG05681
6 · The paper itself

Abstract

background and purposeElevated levels of amyloid deposition as well as white matter damage are thought to be risk factors for Alzheimer Disease (AD). Here we examined whether qualitative ratings of white matter damage predicted cognitive impairment beyond measures of amyloid. MATERIALS AND

methodsThe study examined 397 cognitively normal, 51 very mildly demented, and 11 mildly demented individuals aged 42-90 (mean 68.5). Participants obtained a T2-weighted scan as well as a positron emission tomography scan using (11)[C] Pittsburgh Compound B. Periventricular white matter hyperintensities (PVWMHs) and deep white matter hyperintensities (DWMHs) were measured on each T2 scan using the Fazekas rating scale. The effects of amyloid deposition and white matter damage were assessed using logistic regressions.

resultsLevels of amyloid deposition (ps < 0.01), as well as ratings of PVWMH (p < 0.01) and DWMH (p < 0.05) discriminated between cognitively normal and demented individuals.

conclusionsThe amount of amyloid deposition and white matter damage independently predicts cognitive impairment. This suggests a diagnostic utility of qualitative white matter scales in addition to measuring amyloid levels.

Indexed as

Alzheimer DiseaseAdultAgedAged, 80 and overAmyloidAniline CompoundsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographySeverity of Illness IndexThiazolesWhite Matter2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAmyloidAniline CompoundsThiazolesAlzheimer'sAmyloidBiomarkersMyelinVascularWhite matter

Identifiers

PMID26106548
PMCPMC4474174
OpenAlexW2042009004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.